Literature DB >> 25839635

Cytokine storm after cessation of tocilizumab in a patient with refractory Takayasu arteritis.

Yoh Arita1, Yoshikazu Nakaoka2, Michio Otsuki3, Kaori Higuchi1, Takahiro Hashimoto-Kataoka1, Taku Yasui1, Takeshi Masaki1, Tomohito Ohtani1, Tadamitsu Kishimoto4, Keiko Yamauchi-Takihara1, Issei Komuro5, Yasushi Sakata1.   

Abstract

Entities:  

Keywords:  Cytokine storm; Interleukin-6; Recurrence; Takayasu arteritis (TAK); Tocilizumab

Mesh：

Substances：

Year:  2015        PMID： 25839635     DOI： 10.1016/j.ijcard.2015.03.399

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

Review 1.  Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.

Authors:  Dominika Podgorska; Rafal Podgorski; David Aebisher; Piotr Dabrowski
Journal:  J Appl Biomed       Date:  2019-01-09       Impact factor: 1.797

2.  Comment on: Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study: reply.

Authors:  Yoshikazu Nakaoka; Katsuhisa Yamashita; Shinji Yamakido
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.